Diverse Therapeutics FOMAT operates across a broad range of therapeutic areas including Allergy and Immunology, Cardiology, Family and Internal Medicine, Gastroenterology, Infectious Diseases and Vaccines, Metabolic and Endocrinology, Nephrology, Obstetrics and Gynecology, Ophthalmology and Retina, Oncology, Pediatrics, Rheumatology, Urology and Wound Care, suggesting cross-specialty trial opportunities and the ability to recruit diverse patient populations.

Extensive Site Network With 80 plus sites across multiple states and a focus on community-based care, there is strong potential to streamline site onboarding for sponsors seeking rapid enrollment and geographically distributed patient access, particularly for Phase I to IV studies.

Diversity & Access FOMAT emphasizes diversity and inclusion with a mission to bring trials closer to underserved communities, aligning with sponsors’ goals to enhance representation and meet regulatory expectations for diverse enrollment.

Strategic Growth Recent leadership addition in business development and multiple partnerships with health centers and clinics indicate a growing capability to expand trial networks, accelerate patient outreach, and improve site activation timelines.

Tech & Data Enablement Utilizing a modern tech stack including cloud platforms, analytics tools, and marketing automation suggests capabilities to support trial feasibility, patient recruitment optimization, and remote monitoring, offering value-added services to sponsors.